Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention-Reference-Cited by-同舟云学术

Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention

Published:2005-03 Issue:13 Volume:24 Page:2121-2143
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Jazirehi Ali R,Bonavida Benjamin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1208349.pdf

Reference250 articles.

1. Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS and Rosenberg SA . (1983). J. Clin. Oncol., 1, 11–16.

2. Adra CN, Kobayashi H, Rowley JD and Lim B . (1994). Genomics, 24, 188–190.

3. Alas S, Bonavida B and Emmanouilides C . (2000). Anticancer Res., 20, 2961–2966.

4. Alas S and Bonavida B . (2001). Cancer Res., 61, 5137–5144.

5. Alas S, Emmanouilides C and Bonavida B . (2001). Clin. Cancer Res., 7, 709–723.

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FCGR3A polymorphism : It is helpful for the management of diffuse large B-cell lymphoma;2024-09-02

2. Cross-Talks between Raf Kinase Inhibitor Protein and Programmed Cell Death Ligand 1 Expressions in Cancer: Role in Immune Evasion and Therapeutic Implications;Cells;2024-05-17

3. Carrier systems of radiopharmaceuticals and the application in cancer therapy;Cell Death Discovery;2024-01-09

4. Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy;Frontiers in Oncology;2023-08-03

5. Applying differential network analysis to longitudinal gene expression in response to perturbations;Frontiers in Genetics;2022-10-17